@article{b06ed188b8994fc8b8bb4096162e8a02,
title = "HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab",
keywords = "Anti-PD-1, Autoimmune diabetes, Human immunodeficiency virus, Immune checkpoint inhibitor, Immune-related adverse event",
author = "Elaine Chang and Gustavo Rivero and Patel, {Niraj R.} and Chiao, {Elizabeth Y.} and Syeling Lai and Kelash Bajaj and Mbue, {John E.} and Yellapragada, {Sarvari V.}",
note = "Funding Information: This work was supported by the National Institutes of Health (grant numbers 1R01 CA206479-01 and T32 CA174647) and VA Health Services Research and Development Center of Innovation grant CIN 13-413. The funding source had no role in the study design; collection, analysis or interpretation of data; writing of the report; or in the decision to submit the article for publication.",
year = "2018",
month = feb,
doi = "10.1016/j.clml.2017.12.008",
language = "English (US)",
volume = "18",
pages = "e143--e146",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "2",
}